Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort | British Journal of Cancer
Frontiers | Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches
Prostate Cancer News, Reviews & Views: May 2021
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 12 (2022)
Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancer | Prostate Cancer and Prostatic Diseases
ASCO GUIDELINES Bundle - Noncastrate Advanced, Recurrent or Metastatic Prostate Cancer Initial Management
Oligometastatic cancer: Total Eradication Treatment TET) Trials — Cancer Ecology Center
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Survival Advantage with Frontline Docetaxel in Combination With Hormone Deprivation Therapy in Hormone Sensitive Prostate Cancer | Roswell Park Comprehensive Cancer Center - Buffalo, NY
Trial profile for Scandinavian Prostate Cancer Group 12: Arm A adjuvant... | Download Scientific Diagram
Modern treatment of metastatic prostate cancer | Tidsskrift for Den norske legeforening
Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus | Oncology and Therapy
Treatment of Castration-Resistant Prostate Cancer (CRPC)
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer—Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial - ScienceDirect
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol - The
Current Oncology | Free Full-Text | A Real-World Evidence Study Using Alberta-Population-Based Data to Describe Treatment Patterns for Metastatic Castration-Sensitive Prostate Cancer Patients (AWARENESS)
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
Prostate Cancer - INTRODUCTION - Uroweb
Diagnostics | Free Full-Text | Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions | American Society of Clinical Oncology Educational Book
Salvage therapy for prostate cancer after radical prostatectomy | Nature Reviews Urology
Full article: Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1
Advanced Prostate Cancer: AUA/SUO Guideline - American Urological Association
